Neurocrine Biosciences, Inc.
DE ˙ DB ˙ US64125C1099
134,65 € ↑0,30 (0,22%)
2026-06-03
DEL PRIS
SecurityDE:NB3 / Neurocrine Biosciences, Inc.
InstitutionAsset Management One Co., Ltd.
Latest Disclosed Ownership41,060 shares
Latest Disclosed Value $ 5,409,244
Asset Management One Co., Ltd. reports 7.12% decrease in ownership of NB3 / Neurocrine Biosciences, Inc.

On May 8, 2026 - Asset Management One Co., Ltd. filed a 13F-HR form disclosing ownership of 41,060 shares of Neurocrine Biosciences, Inc. (DE:NB3) valued at $4,588,455 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 44,208 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -7.12% during the quarter. The current value of the position is $5,528,729 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 41,060 -3,148 -7.12 5,409 -14.79 0.0160
2026-01-27 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 44,208 3,336 8.16 6,349 10.65 0.0177
2025-10-22 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 40,872 311 0.77 5,738 12.53 0.0166
2025-07-31 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 40,561 -26,624 -39.63 5,098 -31.39 0.0160
2025-04-23 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 67,185 -3,246 -4.61 7,431 -24.34 0.0257
2025-01-30 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 70,431 1,201 1.73 9,821 23.12 0.0337
2024-10-30 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 69,230 1,705 2.52 7,977 -14.20 0.0284
2024-07-18 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 67,525 30,096 80.41 9,296 80.09 0.0356
2024-05-02 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 37,429 246 0.66 5,162 5.07 0.0199
2024-01-24 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 37,183 -1,479 -3.83 4,914 12.97 0.0198
2023-10-19 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 38,662 207 0.54 4,349 19.94 0.0194
2023-07-31 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 38,455 2,380 6.60 3,626 -0.68 0.0153
2023-04-25 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 36,075 148 0.41 3,652 -15.43 0.0166
2023-02-06 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 35,927 -2,102 -5.53 4,317 6.88 0.0210
2022-11-04 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 38,029 58 0.15 4,039 9.13 0.0206
2022-07-29 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 37,971 -2 -0.01 3,701 3.99 0.0174
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 37,973 -640 -1.66 3,559 9.37 0.0139
2022-02-09 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 38,613 -602 -1.54 3,254 -13.48 0.0113
2021-11-02 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 39,215 166 0.43 3,761 -1.03 0.0144
2021-08-03 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 39,049 -1,045 -2.61 3,800 -2.54 0.0141
2021-05-14 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 40,094 -3,135 -7.25 3,899 -4.11 0.0155
2021-02-12 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 43,229 -8,090 -15.76 4,066 -17.63 0.0167
2020-11-13 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 51,319 -339 -0.66 4,936 -21.71 0.0227
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 51,658 8,569 19.89 6,305 69.08 0.0310
2020-05-14 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 43,089 -15,270 -26.17 3,729 -40.55 0.0218
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 58,359 42,389 265.43 6,273 335.93 0.0283
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,970 0 0.00 1,439 6.75 0.0069
2019-08-14 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,970 5,419 51.36 1,348 44.95 0.0066
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 10,551 10,551 930 0.0050
2017-05-11 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -5,163 -100.00 0 -100.00
2017-05-02 2016-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 5,163 -147,554 -96.62 197 -97.44 0.0005
2017-02-13 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,163 197
2016-11-07 2016-09-30 13F NEUROCRINE BIOSCIENCES Com 64125C109 152,717 -17,650 -10.36 7,686 -0.59 0.1142
2016-08-03 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 170,367 -13,481 -7.33 7,732 13.22 0.1160
2016-05-05 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 183,848 30,349 19.77 6,829 -21.24 0.0997
2016-01-28 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 153,499 10,250 7.16 8,671 69.09 0.1294
2015-11-12 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 143,249 -57,621 -28.69 5,128 -44.27 0.0780
2015-08-06 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 200,870 7,277 3.76 9,201 14.45 0.1275
2015-05-11 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 193,593 -28,094 -12.67 8,039 61.91 0.0993
2015-02-09 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 221,687 66,890 43.21 4,965 99.64 0.0644
2014-11-05 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 154,797 154,797 2,487 0.0343
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.